 |
Pressbox: Roche Diagnostics GmbH
|
Roche's xCELLigence Cardio Instrument Used to Detect Beating Rhythm and Proarrhythmic Effects of Compounds in Stem Cell-Derived Cardiomyocytes
09.02.2012, Research / Development, Roche Diagnostics GmbH
In an effort to improve preclinical cardiotoxicity assays, reduce drug testing attrition rates, and ensure drug safety, collaborating scientists at the University...
|
|
Roche Supports the Smithsonian's National Zoo with Next-Generation Sequencing Instrument for Animal Conservation Research
08.02.2012, Company-internal, Roche Diagnostics GmbH
Roche and the Smithsonian Conservation Biology Institute in Washington, DC announced today a collaboration agreement to use Roche's GS Junior benchtop sequencing...
|
|
Roche Diagnostics Announces Dan Zabrowski as New Head of Roche Applied Science
31.01.2012, Biotechnology, Roche Diagnostics GmbH
As of February 1, 2012, Dan Zabrowski is Head of Roche Applied Science in the Diagnostics Division, located in Penzberg, Germany. He succeeds Paul Brown who has...
|
|
Dan Zabrowski ist neuer Leiter von Roche Applied Science
31.01.2012, Company-internal, Roche Diagnostics GmbH
Seit dem 1. Februar 2012 ist Dan Zabrowski neuer Leiter von Roche Applied Science in der Division Diagnostics mit Sitz in Penzberg. Er tritt damit die Nachfolge...
|
|
Hamilton Introduces Automated DNA Sample Enrichment Solution using Roche 454 REM e System
30.01.2012, Biotechnology, Roche Diagnostics GmbH
Hamilton Robotics announced today a new automated solution for DNA sample enrichment on the MICROLAB STARlet Liquid Handling Workstation. Integrating Roche's REM...
|
|
Neue Forschungsergebnisse in der personalisierten Tumorbehandlung - mit dem Sequenziersystem GS Junior von Roche
17.01.2012, Biotechnology, Roche Diagnostics GmbH
Das Zentrum für Humangenetik und Laboratoriumsmedizin Dr. Klein und Dr. Rost und die IMGM Laboratories GmbH, beide aus Martinsried (Deutschland), haben das kompakte...
|
|
Roche's GS Junior Sequencing System Used in Research on Personalized Tumor Treatment
17.01.2012, Biotechnology, Roche Diagnostics GmbH
The Center for Human Genetics and Laboratory Medicine Dr. Klein and Dr. Rost, and IMGM Laboratories, both located in Martinsried Germany, reported using the Roche...
|
Prof. Dr. Peter Walter erhält Paul Ehrlich- und Ludwig Darmstaedter-Preis 2012
20.12.2011, Research / Development, Roche Diagnostics GmbH
Der Zellbiologe und Biochemiker Prof. Dr. Peter Walter, Professor in der Abteilung für Biochemie und Biophysik an der University of California in San Francisco,...
|
Bremer Professorin Dr. Kathrin Mädler wird mit Paul Ehrlich- und Ludwig Darmstaedter-Nachwuchspreis 2012 ausgezeichnet
20.12.2011, Research / Development, Roche Diagnostics GmbH
Der mit insgesamt 60.000 Euro dotierte Paul Ehrlich- und Ludwig Darmstaedter-Nachwuchspreis 2012 geht an die Bremer Pharmazeutin Prof. Dr. Kathrin Mädler für ihre...
|
|
Roche NimbleGen and BGI develop advanced MHC region capture technology for human disease and biomedical research
28.11.2011, Research / Development, Roche Diagnostics GmbH
Roche NimbleGen, Inc. and BGI, the world's largest genomic organization, announced that they have developed a Major Histocompatibility Complex (MHC) region capture...
|
|
Neue Studie: Biomarker sFlt-1/PIGF korreliert mit Schweregrad der Präeklampsie
17.11.2011, Research / Development, Roche Diagnostics GmbH
Eine neue Studie, die jetzt im American Journal of Obstetrics and Gynecology(1) erschienen ist, zeigt einen hohen Quotienten der Biomarker sFlt-1 (soluble fms-like...
|
|
Roche NimbleGen stellt neues Multiplex-Verfahren für die Schritte vor der Sequenzanreicherung zur Sequenzierung vor
18.10.2011, Research / Development, Roche Diagnostics GmbH
Mit sinkenden Kosten und steigendem Durchsatz von Sequenzierungen benötigen Forscher ein leistungsfähiges und wirtschaftliches Probenvorbereitungssystem für die...
|
|
Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing
11.10.2011, Research / Development, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Arizona Technology Enterprises (AzTE) announced today an agreement to license several technologies developed by Dr. Stuart...
|
|
Roche NimbleGen Announces New Pre-capture Multiplexing for Target Enrichment Technology in Sequencing
10.10.2011, Research / Development, Roche Diagnostics GmbH
With the decreasing cost and increasing throughput of sequencing, researchers require a highperformance, cost-effective sample preparation pipeline for targeted...
|
|
Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment
22.09.2011, Biotechnology, Roche Diagnostics GmbH
A team of researchers from Roche (SIX: RO, ROG; OTCQX: RHHBY), including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported...
